We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$978M
AUM Growth
-$158M
Cap. Flow
-$101M
Cap. Flow %
-10.29%
Top 10 Hldgs %
17.8%
Holding
2,492
New
1,053
Increased
327
Reduced
244
Closed
846

Sector Composition

Rank Sector Weight
1 Technology 17.43%
2 Consumer Discretionary 11.61%
3 Healthcare 10.58%
4 Industrials 10.45%
5 Financials 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMAQW
1401
DELISTED
Blockchain Moon Acquisition Corp. Warrants
BMAQW
$39K ﹤0.01%
+98,450
New +$47.8K
NAAS
1402
NaaS Technology Inc
NAAS
$57.3M
$38K ﹤0.01%
10
+3
+43% +$16.3K
SNTG icon
1403
Sentage Holdings
SNTG
$5.81M
$38K ﹤0.01%
6,207
+3,213
+107% +$30.7K
VERO
1404
DELISTED
Venus Concept
VERO
$38K ﹤0.01%
+136
New +$39.3K
NM
1405
DELISTED
Navios Maritime Holdings Inc.
NM
$38K ﹤0.01%
10,303
-18,819
-65% -$92.9K
SRTAW
1406
DELISTED
Strata Critical Medical Inc Warrants
SRTAW
$37K ﹤0.01%
+16,653
New +$40.7K
DWSN icon
1407
Dawson Geophysical
DWSN
$137M
$37K ﹤0.01%
+15,825
New +$36.4K
GALT icon
1408
Galectin Therapeutics
GALT
$327M
$37K ﹤0.01%
+17,663
New +$50.4K
SMMT icon
1409
Summit Therapeutics
SMMT
$12.4B
$37K ﹤0.01%
+13,649
New +$65.6K
TAOP icon
1410
Taoping
TAOP
$7.74M
$37K ﹤0.01%
+65
New +$54K
BXRX
1411
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$37K ﹤0.01%
122
+33
+37% +$20.7K
DPRO
1412
Draganfly
DPRO
$169M
$36K ﹤0.01%
880
+397
+82% +$28.2K
GDC icon
1413
GD Culture Group
GDC
$7.12M
$36K ﹤0.01%
5
+2
+67% +$19.9K
LITB
1414
LightInTheBox
LITB
$56.5M
$36K ﹤0.01%
+5,985
New +$50.5K
SER icon
1415
Serina Therapeutics
SER
$40.5M
$36K ﹤0.01%
+947
New +$25.6K
KIQ
1416
DELISTED
Kelso Technologies Inc.
KIQ
$36K ﹤0.01%
+81,554
New +$47.5K
HIND
1417
Vyome Holdings
HIND
$15.9M
0
VIVO
1418
VivoPower PLC
VIVO
$125M
$35K ﹤0.01%
+1,163
New +$53K
IMPX.WS
1419
DELISTED
AEA-Bridges Impact Corp Warrants
IMPX.WS
$35K ﹤0.01%
+30,945
New +$26.5K
AIM
1420
AIM ImmunoTech
AIM
$7M
$35K ﹤0.01%
+377
New +$58.3K
INUV icon
1421
Inuvo
INUV
$15.2M
$34K ﹤0.01%
+6,323
New +$40.5K
MBIO icon
1422
Mustang Bio
MBIO
$4.72M
$34K ﹤0.01%
+27
New +$43.6K
SNT
1423
Senstar Technologies
SNT
$42.5M
$34K ﹤0.01%
+11,680
New +$42K
STRR
1424
DELISTED
Star Equity Holdings
STRR
$34K ﹤0.01%
+2,643
New +$34.4K
NIXXW
1425
DELISTED
Nixxy Inc Warrant
NIXXW
$34K ﹤0.01%
+34,120
New +$35.1K

Similar funds

Virtu Financial's Q4 2021 Portfolio in Review

As of Q4 2021, Virtu Financial held 2,492 positions worth $978M, down 14% from $1.14B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Virtu Financial withdrew a net $101M in Q4 2021, closing 846 positions and reducing 244 holdings. Its most notable exit was SPDR Gold Trust, an estimated $87.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Virtu Financial opened a new position in GreenSky, Inc. Class A Common Stock worth $41.9M.

  • Virtu Financial's largest Q4 2021 buy was GreenSky, Inc. Class A Common Stock: 3,684,035 shares worth $41.9M.
  • Virtu Financial added most to DocuSign in Q4 2021, an estimated $11.9M increase.
  • Virtu Financial's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $25.1M.
  • Virtu Financial fully exited SPDR Gold Trust in Q4 2021, selling an estimated $87.9M.
  • Virtu Financial's ten largest holdings make up 18% of its $978M portfolio in Q4 2021.
  • Virtu Financial opened 1,053 new positions and closed 846 in Q4 2021.
  • Virtu Financial's portfolio value fell 14% quarter-over-quarter to $978M.

Based on Virtu Financial's 13F filing for Q4 2021, filed 17 Feb 2022.